Geneos Wealth Management’s Target TGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387K Sell
3,191
-43
-1% -$4.85K 0.01% 770
2025
Q4
$316K Buy
3,234
+313
+11% +$28.8K 0.01% 792
2025
Q3
$262K Sell
2,921
-1,255
-30% -$124K 0.01% 828
2025
Q2
$412K Sell
4,176
-5,086
-55% -$488K 0.01% 769
2025
Q1
$967K Buy
9,262
+7,260
+363% +$907K 0.01% 672
2024
Q4
$271K Buy
2,002
+41
+2% +$5.88K 0.01% 742
2024
Q3
$306K Buy
1,961
+362
+23% +$53.9K 0.01% 655
2024
Q2
$237K Buy
1,599
+192
+14% +$30.2K 0.01% 663
2024
Q1
$249K Sell
1,407
-48
-3% -$7.3K 0.01% 646
2023
Q4
$207K Sell
1,455
-109
-7% -$13.3K 0.01% 666
2023
Q3
$173K Buy
1,564
+336
+27% +$42.7K 0.01% 718
2023
Q2
$162K Sell
1,228
-1,107
-47% -$164K 0.01% 730
2023
Q1
$387K Sell
2,335
-135
-5% -$22.2K 0.02% 495
2022
Q4
$368K Sell
2,470
-348
-12% -$54.6K 0.02% 481
2022
Q3
$418K Sell
2,818
-4,759
-63% -$762K 0.03% 429
2022
Q2
$1.08M Sell
7,577
-608
-7% -$117K 0.05% 303
2022
Q1
$1.74M Buy
8,185
+643
+9% +$139K 0.07% 248
2021
Q4
$1.75M Sell
7,542
-738
-9% -$179K 0.07% 274
2021
Q3
$1.89M Sell
8,280
-114
-1% -$28.6K 0.07% 256
2021
Q2
$2.07M Sell
8,394
-467
-5% -$102K 0.08% 236
2021
Q1
$1.84M Buy
8,861
+105
+1% +$19.7K 0.05% 302
2020
Q4
$1.65M Buy
8,756
+256
+3% +$42.7K 0.07% 261
2020
Q3
$1.31M Sell
8,500
-1,219
-13% -$167K 0.07% 253
2020
Q2
$1.14M Buy
9,719
+102
+1% +$11.6K 0.06% 266
2020
Q1
$911K Buy
9,617
+93
+1% +$10.3K 0.06% 267
2019
Q4
$1.23M Sell
9,524
-377
-4% -$44.2K 0.07% 266
2019
Q3
$1.05M Sell
9,901
-4,217
-30% -$401K 0.06% 261
2019
Q2
$1.22M Sell
14,118
-2,813
-17% -$227K 0.08% 242
2019
Q1
$1.36M Sell
16,931
-1,112
-6% -$81.3K 0.09% 224
2018
Q4
$1.17M Buy
18,043
+694
+4% +$53.4K 0.09% 228
2018
Q3
$1.53M Buy
17,349
+1,861
+12% +$155K 0.1% 210
2018
Q2
$1.18M Sell
15,488
-668
-4% -$49.2K 0.09% 200
2018
Q1
$1.12M Buy
16,156
+738
+5% +$53.7K 0.1% 194
2017
Q4
$1.01M Buy
15,418
+1,028
+7% +$62.1K 0.09% 210
2017
Q3
$849K Sell
14,390
-61,622
-81% -$3.45M 0.08% 224
2017
Q2
$3.99M Buy
76,012
+13,969
+23% +$763K 0.41% 69
2017
Q1
$3.44M Buy
62,043
+50,122
+420% +$3.12M 0.36% 73
2016
Q4
$861K Sell
11,921
-8,978
-43% -$650K 0.11% 177
2016
Q3
$1.44M Buy
20,899
+8,940
+75% +$641K 0.19% 124
2016
Q2
$837K Buy
11,959
+603
+5% +$45K 0.12% 168
2016
Q1
$939K Buy
+11,356
New +$857K 0.14% 157

Other funds holding TGT

Geneos Wealth Management's TGT Position: Q1 2026 in Review

Geneos Wealth Management reduced its Target (TGT) stake by 1.3% in Q1 2026, selling an estimated $4.85K and leaving 3,191 shares worth $387K. The position accounts for 0.01% of the portfolio, ranked #770.

Geneos Wealth Management first reported a position in TGT in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.99M in Q2 2017. 1,839 funds tracked by Wall St. Rank hold TGT as of Q1 2026.

  • Geneos Wealth Management held 3,191 shares of Target worth $387K as of Q1 2026.
  • Geneos Wealth Management sold 43 Target shares in Q1 2026, an estimated $4.85K.
  • Target made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #770 holding.
  • Geneos Wealth Management first reported a position in Target in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Target position peaked at $3.99M in Q2 2017.
  • 1,839 funds tracked by Wall St. Rank held Target as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.